OQS
CVAC

Occudo Quantitative Strategies’s CureVac CVAC Stock Holding History

Occudo Quantitative Strategies’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,540
Closed -$132K – 795
2024
Q1 		$132K Buy
43,540
+28,257
+185% +$99.2K 0.02% 630
2023
Q4 		$64.3K Buy
+15,283
New +$82.9K 0.01% 732
2022
Q4 		– Sell
-49,034
Closed -$386K – 1050
2022
Q3 		$386K Buy
+49,034
New +$572K 0.03% 756
2022
Q2 		– Sell
-52,996
Closed -$1.04M – 1178
2022
Q1 		$1.04M Buy
+52,996
New +$1.06M 0.09% 371

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's CVAC Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of CureVac (CVAC) in Q2 2024, closing a stake of 43,540 shares — an estimated $132K sold.

Occudo Quantitative Strategies first reported a position in CVAC in Q1 2022 and held it in 4 quarters. The position peaked at $1.04M in Q1 2022. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 43,540 CureVac shares in Q2 2024, an estimated $132K.
  • Occudo Quantitative Strategies first reported a position in CureVac in Q1 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's CureVac position peaked at $1.04M in Q1 2022.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.